Diclofenac Sodium/Menthol

双氯芬酸钠/薄荷脑

Report date: 2022/04/12 18:38:40

Base Information

Drug NameDiclofenac Sodium/Menthol
Drug Alias NameMenthol/Diclofenac薄荷脑/双氯芬酸钠Menthol/Diclofenac SodiumDiclofenac/MentholMFC-51123
ClassificationSmall molecules
Mechanisms of ActionCyclooxygenases inhibitorsTransient receptor potential cation channel subfamily M member 8 agonists
TargetsTransient receptor potential cation channel subfamily M member 8Cyclooxygenases
Therapy Area/IndicationsPain
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsYes Diclofenac SodiumMenthol
Global Highest StatusDiscontinued (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesGlaxosmithkline Plc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGlaxosmithkline Plc
Active IndicationsN/A
Inactive IndicationsPain

Other Information

ATC CodeN/A
Related LinksN/A